Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jean Philippe Spano
Based on 20 articles published since 2009
(Why 20 articles?)
||||
Expertise Level
The expertise of Jean Philippe Spano ranks in the
  • Top 0.56%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Spano, J P   ·   Spano, Jean-Philippe   ·   Spano, Jean Philippe   ·   Spano, J-P
Work Locations
Details
Most likely:    Sorbonne University      
2017
  • University Hospital Jean Minjoz, INSERM 1098, Besancon, France. Electronic address: · AP-HP Pitié-Salpêtrière-Charles Foix, UPMC Université Paris 06, Paris, France. · Hôpital Saint Louis, AP-HP, Paris, France. · Institut Curie, Paris, France. · Institut Jean Godinot, Reims, France. · Centre Leonard De Vinci, Dechy, France. · Pôle Santé République - Clinique Clermont-Ferrand, Clermont Ferrand, France. · Institut Paoli-Calmettes, Marseille, France. · Centre Catherine de Sienne, Nantes, France. · Institut Claudius-Regaud, Toulouse, France. · Gentilly Oncology Centre, Nancy, France. · Roche, Boulogne-Billancourt, France. · APHP Tenon, Inserm U938, IUC-UPMC Sorbonne Université, Paris, France. · Pubmed 28648618
2015
  • Department of Medical Oncology, GHPS-CFX, APHP, IUC/UPMC, INSERM_UMRS1136, Paris, France. Electronic address: · Department of Radiation Oncology, Institut du Cancer Montpellier - Val d'Aurelle (ICM), Montpellier, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Cancer Research Center of Marseille, Aix-Marseille University, Marseille, France. · Pubmed 25682223
  • Département de neurochirurgie, centre hospitalo-universitaire La Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France; Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Centre de recherche en oncologie et oncopharmacologie (CRO2), faculté de médecine Timone, université Aix-Marseille, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France; Inserm U911, faculté de médecine Timone, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France. Electronic address: · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service d'oncologie-radiothérapie, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie-radiothérapie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de neurochirurgie, hôpital Roger-Salengro, CHRU, rue Émile-Laine, 59037 Lille cedex, France. · Département de neurologie, hôpital Avicenne, Assistance publique-Hôpitaux de Paris (AP-HP), 125, rue de Stalingrad, 93009 Bobigny cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie médicale, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie-radiothérapie, centre de lutte contre le cancer Val-d'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier cedex 5, France. · Département universitaire de radiothérapie, centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, BP 42, 67065 Strasbourg cedex, France; Laboratoire EA3430, fédération de médecine translationnelle de Strasbourg (FMTS), université de Strasbourg, 4, rue Kirschleger, 67085 Strasbourg cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service d'oncologie multidisciplinaire et d'innovation thérapeutique, hôpital Nord, chemin des Bourrely, 13915 Marseille cedex 20, France. · Département de neurologie 2, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Département de radiothérapie, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Université Pierre-et-Marie-Curie Paris VI, 4, place Jussieu, 75005 Paris, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service de neuro-oncologie, département de neurochirurgie, hôpital Roger-Salengro, CHRU de Lille, rue Émile-Laine, 59037 Lille cedex, France; Service d'oncologie médicale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France; Laboratoire Prism, université Lille 1, bâtiment SN3 1(er) étage, 59655 Villeneuve d'Ascq cedex, France; Inserm U1192, 59655 Villeneuve d'Ascq cedex, France. · Pubmed 25649388
  • AP-HP, DRCD, Paris, France. · Sorbonne Universités, UPMC Université Paris 06, UFR de Médecine, Paris, France. · Hôpital des Diaconesses, Pôle oncologie médicale, Paris, France. · CH Lagny Marne la Vallée, Service de Radiothérapie-Oncologie, Lagny, France. · Université Paris 13, UFR SMBH, Bobigny, France; AP-HP, Hôpital Avicenne, Service d'oncologie médicale, Bobigny, France. · Institut de Cancérologie des Peupliers, Paris, France. · AP-HP, Hôpital St-Antoine, Service d'oncologie médicale, Paris, France. · AP-HP, Hôpital St-Antoine, URC-EST, Paris, France. · Fujitsu (Ireland) Limited, Swords, Co. Dublin, Ireland. · Sorbonne Universités, UPMC Université Paris 06, UMR_S 1142, LIMICS, Paris, France ; INSERM, U1142, LIMICS, Paris, France; Université Paris 13, Sorbonne Paris Cité, LIMICS (UMR_S 1142), Bobigny, France. · Pubmed 26262052
  • Assistance Publique - Hôpitaux de Paris (APHP), Groupe Hospitalier Pitié-Salpétrière, Medical Oncology Department led by Prof. David Khayat, Cancer University Institute, 47 Bd de l'Hôpital, F-75013 Paris, France. · Institut Curie, 26 rue d'Ulm, F-75005 Paris, France. · Institut du Cancer Reims, 38 rue de Courlancy, F-51100 Reims, France. · Centre Georges-François-Leclerc, Département de biologie et de pathologie des Tumeurs, 1 rue du Pr. Marion, F-21034 Dijon, France. · Centre Catherine de Sienne, Service de Chimiothérapie, 2 rue Éric Tabarly, F-44202 Nantes, France. · Institut Gustave Roussy, 39 rue Camilles-Desmoulins, F-94805 Villejuif, France. · Centre Antoine Lacassagne, 33 Avenue de Valombrose, F-06100 Nice, France. Electronic address: · Pubmed 25913287
2014
  • Department of Radiation Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Department of Radiation Oncology and INSERM U896, CRLC Val d'Aurelle, Montpellier 34000, France. · Breast Unit, Department of Medical Oncology, Oscar Lambret Center, Lille Cedex 59020, France. · Multidisciplinary Oncology and Therapeutic Innovations Department & Centre Investigation Clinique, Aix Marseille University-Assistance Publique Hôpitaux de Marseille, Marseille 13011, France. · Department of Neurology, Hopital Avicenne, Assistance Publique des Hopitaux de Paris, Bobigny 93000, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Department of Radiation Oncology and Department of Neuro-Oncology, Pitié-Salpétrière Hospital, Paris 75013, France. · Department of Radiation Oncology, Institut Gustave Roussy University Hospital, Villejuif 94805, France. · Department of Medical Oncology, GH Pitié-Salpêtrière, Université Paris 6, Paris 75013, France. · Department of Radiation Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Pubmed 24815073
  • Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. Electronic address: · Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. · Department of Oncology and Radiotherapy CRLC Val d'Aurelle, Montpellier, France. · Department of Oncology, Beaujon-Bichat Inter-Hospital, Clichy, France. · Department of Pathology, Jean Perrin Center and EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · Pubmed 24462377
  • AP-HP, DRCD, Paris, France ; INSERM, U1142, LIMICS, Paris, France ; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1142, LIMICS, Paris, France ; Université Paris 13, Sorbonne Paris Cité, LIMICS, (UMR_S 1142), Bobigny, France. · CH Lagny Marne la Vallée, Service de radiothérapie-oncologie, Lagny, France. · Université Paris 13, Sorbonne Paris Cité, UFR SMBH, Bobigny, France; AP-HP, Hôpital Avicenne, Service d'oncologie médicale, Bobigny, France. · Sorbonne Universités, UPMC Univ Paris 06, UFR de médecine, Paris, France ; AP-HP, Hôpital Pitié-Salpétrière, Service d'oncologie médicale, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UFR de médecine, Paris, France ; AP-HP, Hôpital Pitié-Salpétrière, Service de chirurgie et cancérologie gynécologique et mammaire, Paris, France. · Hôpital des Diaconesses, Pôle oncologie médicale, Paris, France. · Institut de Cancérologie des Peupliers, Paris, France. · AP-HP, Hôpital St-Antoine, Service d'oncologie médicale, Paris, France. · AP-HP, Hôpital St-Antoine, URC-EST, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1142, LIMICS, Paris, France ; INSERM, U1142, LIMICS, Paris, France ; Université Paris 13, Sorbonne Paris Cité, LIMICS, (UMR_S 1142), Bobigny, France ; AP-HP, Hôpital Tenon, Département de santé publique, Paris, France; APREC, Paris, France. · Pubmed 25954334
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Groupe Hospitalier Pitié-Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie (Paris VI), Institut Universitaire de Cancérologie, AP-HP, Paris, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology Program, New York University Cancer Institute, New York, NY, USA. · Pubmed 25296969
2012
  • AP-HP, Groupe Hospitalier Pitié-Salpétrière, Département d'Oncologie Médicale du Prof. David Khayat, 47 Boulevard de l'Hôpital, Paris, France. · Pubmed 22766516
2011
  • Groupe Hospitalier de la Pitié-Salpétrière, Département d’Oncologie Médicale du Prof. David Khayat, Paris, France. · Pubmed 21705664
2013
  • UPMC, UFR de Médecine, Sorbonne Universités, Paris, France. · Pubmed 23920612
2011
  • CNRS USR 3246, CR-ICM, Pitié-Salpêtrière Hospital, Paris, France. · Pubmed 22016764
Probable:    Institut Universitaire de France      
2014
  • Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Groupe Hospitalier Pitié-Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie (Paris VI), Institut Universitaire de Cancérologie, AP-HP, Paris, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology Program, New York University Cancer Institute, New York, NY, USA. · Pubmed 25296969
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Jean Philippe Spano about Breast Neoplasms:

  • Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study. 2017
  • Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy. 2015
  • [Global brain metastases management strategy: a multidisciplinary-based approach]. 2015
  • [Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria]. 2015
  • Physicians' Attitudes Towards the Advice of a Guideline-Based Decision Support System: A Case Study With OncoDoc2 in the Management of Breast Cancer Patients. 2015
  • Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA. 2015
  • Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer. 2014
  • Resistance to human epidermal growth factor receptor type 2-targeted therapies. 2014
  • Health information technology: use it well, or don't! Findings from the use of a decision support system for breast cancer management. 2014
  • Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. 2014
Show List of Full Article Records
Public Errors
Google Searches

Learn more about Jean Philippe Spano using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Sorbonne University
Institut Universitaire de France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Sorbonne University
2017
  • University Hospital Jean Minjoz, INSERM 1098, Besancon, France. Electronic address: · AP-HP Pitié-Salpêtrière-Charles Foix, UPMC Université Paris 06, Paris, France. · Hôpital Saint Louis, AP-HP, Paris, France. · Institut Curie, Paris, France. · Institut Jean Godinot, Reims, France. · Centre Leonard De Vinci, Dechy, France. · Pôle Santé République - Clinique Clermont-Ferrand, Clermont Ferrand, France. · Institut Paoli-Calmettes, Marseille, France. · Centre Catherine de Sienne, Nantes, France. · Institut Claudius-Regaud, Toulouse, France. · Gentilly Oncology Centre, Nancy, France. · Roche, Boulogne-Billancourt, France. · APHP Tenon, Inserm U938, IUC-UPMC Sorbonne Université, Paris, France. · Pubmed 28648618
2015
  • Department of Medical Oncology, GHPS-CFX, APHP, IUC/UPMC, INSERM_UMRS1136, Paris, France. Electronic address: · Department of Radiation Oncology, Institut du Cancer Montpellier - Val d'Aurelle (ICM), Montpellier, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Cancer Research Center of Marseille, Aix-Marseille University, Marseille, France. · Pubmed 25682223
  • Département de neurochirurgie, centre hospitalo-universitaire La Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France; Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Centre de recherche en oncologie et oncopharmacologie (CRO2), faculté de médecine Timone, université Aix-Marseille, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France; Inserm U911, faculté de médecine Timone, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France. Electronic address: · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service d'oncologie-radiothérapie, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie-radiothérapie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de neurochirurgie, hôpital Roger-Salengro, CHRU, rue Émile-Laine, 59037 Lille cedex, France. · Département de neurologie, hôpital Avicenne, Assistance publique-Hôpitaux de Paris (AP-HP), 125, rue de Stalingrad, 93009 Bobigny cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie médicale, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Département d'oncologie-radiothérapie, centre de lutte contre le cancer Val-d'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier cedex 5, France. · Département universitaire de radiothérapie, centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, BP 42, 67065 Strasbourg cedex, France; Laboratoire EA3430, fédération de médecine translationnelle de Strasbourg (FMTS), université de Strasbourg, 4, rue Kirschleger, 67085 Strasbourg cedex, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service d'oncologie multidisciplinaire et d'innovation thérapeutique, hôpital Nord, chemin des Bourrely, 13915 Marseille cedex 20, France. · Département de neurologie 2, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Département de radiothérapie, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Université Pierre-et-Marie-Curie Paris VI, 4, place Jussieu, 75005 Paris, France. · Groupe de réflexion sur la prise en charge des métastases cérébrales (GRPCMaC), 13273 Marseille cedex 09, France; Service de neuro-oncologie, département de neurochirurgie, hôpital Roger-Salengro, CHRU de Lille, rue Émile-Laine, 59037 Lille cedex, France; Service d'oncologie médicale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France; Laboratoire Prism, université Lille 1, bâtiment SN3 1(er) étage, 59655 Villeneuve d'Ascq cedex, France; Inserm U1192, 59655 Villeneuve d'Ascq cedex, France. · Pubmed 25649388
  • AP-HP, DRCD, Paris, France. · Sorbonne Universités, UPMC Université Paris 06, UFR de Médecine, Paris, France. · Hôpital des Diaconesses, Pôle oncologie médicale, Paris, France. · CH Lagny Marne la Vallée, Service de Radiothérapie-Oncologie, Lagny, France. · Université Paris 13, UFR SMBH, Bobigny, France; AP-HP, Hôpital Avicenne, Service d'oncologie médicale, Bobigny, France. · Institut de Cancérologie des Peupliers, Paris, France. · AP-HP, Hôpital St-Antoine, Service d'oncologie médicale, Paris, France. · AP-HP, Hôpital St-Antoine, URC-EST, Paris, France. · Fujitsu (Ireland) Limited, Swords, Co. Dublin, Ireland. · Sorbonne Universités, UPMC Université Paris 06, UMR_S 1142, LIMICS, Paris, France ; INSERM, U1142, LIMICS, Paris, France; Université Paris 13, Sorbonne Paris Cité, LIMICS (UMR_S 1142), Bobigny, France. · Pubmed 26262052
  • Assistance Publique - Hôpitaux de Paris (APHP), Groupe Hospitalier Pitié-Salpétrière, Medical Oncology Department led by Prof. David Khayat, Cancer University Institute, 47 Bd de l'Hôpital, F-75013 Paris, France. · Institut Curie, 26 rue d'Ulm, F-75005 Paris, France. · Institut du Cancer Reims, 38 rue de Courlancy, F-51100 Reims, France. · Centre Georges-François-Leclerc, Département de biologie et de pathologie des Tumeurs, 1 rue du Pr. Marion, F-21034 Dijon, France. · Centre Catherine de Sienne, Service de Chimiothérapie, 2 rue Éric Tabarly, F-44202 Nantes, France. · Institut Gustave Roussy, 39 rue Camilles-Desmoulins, F-94805 Villejuif, France. · Centre Antoine Lacassagne, 33 Avenue de Valombrose, F-06100 Nice, France. Electronic address: · Pubmed 25913287
2014
  • Department of Radiation Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Department of Radiation Oncology and INSERM U896, CRLC Val d'Aurelle, Montpellier 34000, France. · Breast Unit, Department of Medical Oncology, Oscar Lambret Center, Lille Cedex 59020, France. · Multidisciplinary Oncology and Therapeutic Innovations Department & Centre Investigation Clinique, Aix Marseille University-Assistance Publique Hôpitaux de Marseille, Marseille 13011, France. · Department of Neurology, Hopital Avicenne, Assistance Publique des Hopitaux de Paris, Bobigny 93000, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Department of Radiation Oncology and Department of Neuro-Oncology, Pitié-Salpétrière Hospital, Paris 75013, France. · Department of Radiation Oncology, Institut Gustave Roussy University Hospital, Villejuif 94805, France. · Department of Medical Oncology, GH Pitié-Salpêtrière, Université Paris 6, Paris 75013, France. · Department of Radiation Oncology, Institut Paoli Calmettes, Marseille 13009, France. · Pubmed 24815073
  • Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. Electronic address: · Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. · Department of Oncology and Radiotherapy CRLC Val d'Aurelle, Montpellier, France. · Department of Oncology, Beaujon-Bichat Inter-Hospital, Clichy, France. · Department of Pathology, Jean Perrin Center and EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · Pubmed 24462377
  • AP-HP, DRCD, Paris, France ; INSERM, U1142, LIMICS, Paris, France ; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1142, LIMICS, Paris, France ; Université Paris 13, Sorbonne Paris Cité, LIMICS, (UMR_S 1142), Bobigny, France. · CH Lagny Marne la Vallée, Service de radiothérapie-oncologie, Lagny, France. · Université Paris 13, Sorbonne Paris Cité, UFR SMBH, Bobigny, France; AP-HP, Hôpital Avicenne, Service d'oncologie médicale, Bobigny, France. · Sorbonne Universités, UPMC Univ Paris 06, UFR de médecine, Paris, France ; AP-HP, Hôpital Pitié-Salpétrière, Service d'oncologie médicale, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UFR de médecine, Paris, France ; AP-HP, Hôpital Pitié-Salpétrière, Service de chirurgie et cancérologie gynécologique et mammaire, Paris, France. · Hôpital des Diaconesses, Pôle oncologie médicale, Paris, France. · Institut de Cancérologie des Peupliers, Paris, France. · AP-HP, Hôpital St-Antoine, Service d'oncologie médicale, Paris, France. · AP-HP, Hôpital St-Antoine, URC-EST, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1142, LIMICS, Paris, France ; INSERM, U1142, LIMICS, Paris, France ; Université Paris 13, Sorbonne Paris Cité, LIMICS, (UMR_S 1142), Bobigny, France ; AP-HP, Hôpital Tenon, Département de santé publique, Paris, France; APREC, Paris, France. · Pubmed 25954334
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Groupe Hospitalier Pitié-Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie (Paris VI), Institut Universitaire de Cancérologie, AP-HP, Paris, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology Program, New York University Cancer Institute, New York, NY, USA. · Pubmed 25296969
2012
  • AP-HP, Groupe Hospitalier Pitié-Salpétrière, Département d'Oncologie Médicale du Prof. David Khayat, 47 Boulevard de l'Hôpital, Paris, France. · Pubmed 22766516
2011
  • Groupe Hospitalier de la Pitié-Salpétrière, Département d’Oncologie Médicale du Prof. David Khayat, Paris, France. · Pubmed 21705664
2013
  • UPMC, UFR de Médecine, Sorbonne Universités, Paris, France. · Pubmed 23920612
2011
  • CNRS USR 3246, CR-ICM, Pitié-Salpêtrière Hospital, Paris, France. · Pubmed 22016764
Institut Universitaire de France
2014
  • Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Groupe Hospitalier Pitié-Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie (Paris VI), Institut Universitaire de Cancérologie, AP-HP, Paris, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breast Medical Oncology Program, New York University Cancer Institute, New York, NY, USA. · Pubmed 25296969
6 Other Locations Show
Yearly article counts 00105523400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.